is a licensed medical doctor, trained in neurology, psychiatry and psychotherapy, with more than 25 years of professional experience within healthcare, including clinical medicine, pharmaceutical and medical device industry und the German pharmaceutical industry association, BPI.
In 2018, Dr. Breitkopf founded her own consultancy advising healthcare industry, scientific associations und further institutions in all challenges concerning pharmaceutical medicine, clinical research and market access.
She is engaged in several industry and scientific associations, including DGPharMed e. V., where she is a board member and acts as an official delegate to IFAPP.org and German AWMF.org and to the newly founded Registry Working Group within the TMF e. V.